首页> 外国专利> 1,3,4,9-TETRAHYDRO (PYRANO OR THIOPYRANO) 3,4-B - INDOLE DERIVATIVES

1,3,4,9-TETRAHYDRO (PYRANO OR THIOPYRANO) 3,4-B - INDOLE DERIVATIVES

机译:1,3,4,9-四氢呋喃(吡喃或硫代吡喃)[3,4-B]-吲哚衍生物

摘要

1391005 1,3,4,9 - Tetrahydro - (pyrano or thiopyrano) [3,4-6] indole derivatives AMERICAN HOME PRODUCTS CORP 1 June 1972 [1 June 1971] 25605/72 Heading C2C Novel compounds I in which R 1 is C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-6 cycloalkyl, phenyl, benzyl or 2- thienyl, R 2 , R 3 B 4 and B 5 are hydrogen or C 1-6 alkyl, R 7 is hydrogen, C 1-6 alkyl or C 2-6 alkenyl, X is oxygen or sulphur, Y is -CO-, or. (in which R 8 , R 9 , R 10 , R 11 , R 12 and R 13 are hydrogen or C 1-6 alkyl), Z is hydroxy, C 1-4 alkoxy amino, mono- or di- (C 1-6 alkyl) amino or phenylamino and R 6 is hydrogen, C 1-6 alkyl, hydroxy, C 1-4 alkoxy, benzyloxy, C 2-6 alkanoyloxy nitro or halogen or R 6 is one to four substituents selected from halogen, C 1-6 alkyl, hydroxy, C 1-4 alkoxy benzyloxy, C 2-6 alkanyloxy, nitro, mercapto, C 1-6 alkylthio, halo C 1-6 (preferably trifluoromethyl) amino or;sulphamoyl and their addition salts are prepared by reacting a compound II in which XSP1/SP is hydroxy or mercapto with a compound R 1 -CO-Y-Z in the presence of an acid catalyst. Compounds I in which Z is hydroxy are also prepared by reacting compound II with a compound in which YSP1/SP is CH 2 , -CR 8 C 9 -CH 2 -, or -CR 8 R 9 -CR 10 R 11 -CR 12 R 13 -CH 2 and R 17 is hydrogen or C 1-6 alkyl to form a compound IX which is hydrolysed to the corresponding primary alcohol which is oxidized to the aldehyde and then to the acid. Amide derivatives of Formula I are also prepared from the acids (Z is OH) by reaction with the ethylchloroformate and the appropriate amine or from the ester (Z is C 1-6 alkyl) by treatment with the amine. Compounds I in which R 7 is C 1-6 alkyl or C 2-6 alkenyl are also prepared by N-alkylation of compounds I in which R 7 is hydrogen. Compounds I show anti-inflammatory, analgesic, anti-bacterial and anti-fungal activity and form with a carrier a pharmaceutical composition which may be administered orally or parenterally or topically. Compounds I are also utilized in disinfectant and antiseptic wash solutions.
机译:1391005 1,3,4,9-四氢-(吡喃基或硫代吡喃基)[3,4-6]吲哚衍生物AMERICAN HOME PRODUCTS CORP 1972年6月1日[1971年6月1日] 25605/72标题C2C新型化合物I,其中R 1是C 1-6烷基,C 2-6烯基,C 2-6炔基,C 3-6环烷基,苯基,苄基或2-噻吩基,R 2,R 3 B 4和B 5为氢或C 1-6烷基R 7为氢,C 1-6烷基或C 2-6烯基,X为氧或硫,Y为-CO-,或。 (其中R 8,R 9,R 10,R 11,R 12和R 13为氢或C 1-6烷基),Z为羟基,C 1-4烷氧基氨基,单-或双-(C 1- 6烷基)氨基或苯氨基,R 6为氢,C 1-6烷基,羟基,C 1-4烷氧基,苄氧基,C 2-6烷酰氧基硝基或卤素,或R 6为选自卤素,C 1的1-4个取代基-6烷基,羟基,C 1-4烷氧基苄氧基,C 2-6烷氧基,硝基,巯基,C 1-6烷硫基,卤代C 1-6(优选三氟甲基)氨基或磺酰基及其加成盐通过反应制备化合物Ⅱ,其中X 1 是羟基或巯基,在酸催化剂存在下与化合物R 1 -CO-YZ。 Z为羟基的化合物I也可通过使化合物II与Y 1 为CH 2,-CR 8 C 9 -CH 2-或-CR 8 R 9 -CR的化合物反应来制备。 10 R 11 -CR 12 R 13 -CH 2和R 17为氢或C 1-6烷基,形成化合物IX,将其水解为相应的伯醇,该伯醇被氧化为醛,然后被氧化为酸。式I的酰胺衍生物也可以通过酸(Z为OH)与氯甲酸乙酯和适当的胺反应而制得,或者由酯(Z为C 1-6烷基)经胺处理而制得。还通过其中R 7为氢的化合物I的N-烷基化来制备其中R 7为C 1-6烷基或C 2-6烯基的化合物I。化合物I显示出抗炎,止痛,抗细菌和抗真菌的活性,并与载体一起形成药物组合物,该药物组合物可以口服,肠胃外或局部给药。化合物I还用于消毒剂和防腐剂洗涤溶液中。

著录项

  • 公开/公告号MY7800237A

    专利类型

  • 公开/公告日1978-12-31

    原文格式PDF

  • 申请/专利权人 AMERICAN HOME PRODUCTS CORPORATION;

    申请/专利号MY19780000237

  • 发明设计人

    申请日1978-12-30

  • 分类号C07D495/04;

  • 国家 MY

  • 入库时间 2022-08-22 20:30:42

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号